A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
Phase 1
- Conditions
- Prostate Cancer
- Interventions
- Biological: Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2011-07-11
- Lead Sponsor
- Biotech Equity Partners Pty Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT00625430
- Locations
- 🇦🇺
St Vincent's Hospital, Sydney, Darlinghurst, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath